Inventor

Gere S. diZerega

Inventor
Pasadena, CA, US

Overview

69→
Patents
1988–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 69 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes40%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07KPeptides17%
C12NMicroorganisms or enzymes8%
A61LMethods or apparatus for sterilising materials or objects in general2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
C07DHeterocyclic compounds1%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%
A61FFilters implantable into blood vessels1%
C08LCompositions of macromolecular compounds1%
PatentTitleYear
11,058,639Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer202111,033,542Methods for solid tumor treatment202110,894,045Methods for solid tumor treatment202110,874,660Methods for solid tumor treatment202010,842,736Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes202010,555,898Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes202010,507,181Methods for treating lung disorders201910,398,646Methods for treating lung disorders201910,391,090Methods for solid tumor treatment201910,301,298Methods, compounds, and compositions for the treatment of angiotensin-related diseases201910,195,282Use of alginate formulation for intraincisional drug delivery20199,943,509Methods, compounds, and compositions for the treatment of musculoskeletal diseases20189,844,578Accelerated healing of eye injuries by angiotensin peptides20179,732,074'Methods, compounds, and compositions for the treatment of angiotensin-related diseases'20179,688,724'Methods for limiting development of a skin wound'20179,623,084'Methods for treating multiple sclerosis'20179,272,013'Methods for treating combined radiation and thermal injury'20168,536,231'Methods for treating diabetic foot ulcers'20138,207,233'Methods for treating diabetic foot ulcers'20128,207,234'Methods for treating diabetic foot ulcers'20127,786,085'Method for treating a patient undergoing chemotherapy'20107,776,828'Radiation therapy methods'20107,745,411'Methods for promoting erythropoiesis'20107,744,927'Methods of promoting hematopoietic and mesenchymal cell proliferation and differentiation'20107,338,938'Methods for treating a patient undergoing chemotherapy'20087,288,522'Method of promoting erythropoiesis'20077,176,183'Methods for treating and preventing damage to mucosal tissue'20077,173,011'Radiation therapy methods'20077,122,523'Methods for inhibiting tumor cell proliferation'20067,118,748'Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation'20067,022,675'Wound healing compositions'20066,916,783'Methods for accelerating bone and cartilage growth and repair'20056,821,953'Methods for treating and preventing damage to mucosal tissue'20046,762,167'Methods for treating a patient undergoing chemotherapy'20046,747,008'Methods for treating and preventing alopecia'20046,730,775'Methods for limiting scar and adhesion formation'20046,566,335'Methods for mobilizing hematopoietic progenitor cells from bone marrow into peripheral blood in a patient in need of chemotherapy'20036,498,138'Method of promoting production of living tissue equivalents'20026,482,800'Methods to stimulate angiogenesis'20026,475,988'Methods to increase white blood cell survival after chemotherapy'20026,455,501'Wound healing compositions'20026,455,500'Radiation therapy methods'20026,444,646'Use of angiotensin II type 2 receptor agonists in tissue repair'20026,335,195'Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation'20026,258,778'Methods for accelerating bone and cartilage growth and repair'20016,248,587'Method for promoting mesenchymal stem and lineage-specific cell proliferation'20016,239,109'Method of promoting erythropoiesis'20016,177,407'Methods to increase blood flow to ischemic tissue'20016,165,978'Wound healing composition'20006,110,895'Method of promoting healing in skin grafts'20006,096,709'Use of angiotensin II fragments and analogs thereof in tissue repair'20005,955,430'Use of angiotensin II fragments and analogs thereof in tissue repair'19995,891,460'Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof'19995,834,432'Use of angiotensin II Type 2 receptor agonists in tissue repair'19985,807,833'Hydroxyethyl starch and use thereof as an absorbable mechanical barrier and intracavity carrier device'19985,716,935'Use of antiotensin II analogs in tissue repair'19985,639,468'Method for reducing or preventing post-surgical adhesion formation using manoalide and analogs thereof'19975,629,292'Use of angiotensin III and analogs thereof in tissue repair'19975,629,294'Compositions and methods for preventing adhesion formation'19975,614,515'Lazaroid-based compositions and method for preventing adhesion formation using the same'19975,534,261'Retinoid-based compositions and method for preventing adhesion formation using the same'19965,498,613'Dipyridamole and analogs thereof in preventing adhesion formation'19965,478,837'Use of quinacrine in preventing adhesion formation'19955,173,404'Immunoassay for follicular regulatory protein'19925,015,629'Tissue repair'19914,937,254'Method for inhibiting post-surgical adhesion formation by the topical administration of non-steroidal anti-inflammatory drug'19904,889,722'Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator'19894,764,502'Intragonadal regulatory protein'19884,734,398'Follicular regulating protein'1988

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1988–2019Patents assigned to UNIV SOUTHERN CALIFORNIA (56)· patent assignee history
1988–2010Based in Pasadena, CA, US· patent location history
2000–2005Based in Pasedena, CA, US· patent location history
2004–2019Based in Los Angeles, CA, US· patent location history
2006–2019Based in San Luis Obispo, CA, US· patent location history
2012–2017Patents assigned to DIZEREGA GERE S (5)· patent assignee history
2012–2017Patents assigned to RODGERS KATHLEEN E (5)· patent assignee history
2019–2021Patents assigned to CRITITECH INC (7)· patent assignee history
2019–2021Based in Lawrence, KS, US· patent location history
2020Patents assigned to DFB SORIA LLC (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV SOUTHERN CALIFORNIA561988–2019
CRITITECH INC72019–2021
DIZEREGA GERE Sself52012–2017
RODGERS KATHLEEN E52012–2017
DFB SORIA LLC22020
Locations
LocationPatentsSpan
Pasadena, California, US391988–2010
San Luis Obispo, California, US142006–2019
Lawrence, KS, US72019–2021
Los Angeles, California, US42004–2019
Pasedena, California, US32000–2005